Bioinspired Ultrastable Cu(I)-Bovine Serum Albumin Single-Atom Nanozymes Enable MRI-Trackable Synergistic Catalytic Therapy and Cuproptosis for Tumors
- 17 September 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (38) , 34368-34383
Abstract
Monovalent copper (Cu(I)) drives cuproptosis and catalytic therapy, yet its rapid oxidation reduces the activity. We developed bioinspired Cu(I)-bovine serum albumin single-atom nanozymes (Cu(I)-BSA SAzymes) via mild biomineralization, achieving stability (>90 days) and dual enzyme-like activities (peroxidase (POD)/catalase (CAT)) to convert tumor H2O2 into cytotoxic reactive oxygen species (ROS) while alleviating hypoxia. These SAzymes deplete glutathione to amplify oxidative stress and release Cu(I), which aggregates dihydrolipoamide S-acetyltransferase (DLAT) to induce cuproptosis─distinct from apoptosis/ferroptosis. Mechanistically, transcriptomics analyses suggest that Cu(I)-BSA SAzymes exerted their effects by regulating the oxidative stress and energy metabolism in 4T1 cells. The tumor microenvironment further mediates SAzymes aggregation and in situ transformation into paramagnetic Cu(II), enabling self-amplified T1-weighted MRI contrast for real-time activation monitoring. In breast (4T1) and colon (CT26) tumors, Cu(I)-BSA SAzymes suppress growth by 68.8% and 80.3% ([Cu] = 4 mg kg-1). This study reports a stable Cu(I) platform for catalytic-plus-cuproptosis theranostics.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFB3804500)
- Shanghai Municipal Health Commission (20224Y0013)
- National Natural Science Foundation of China (32401150, 32571586, 82272055, 82272137)
- Start-up Fund from Tongji Hospital (RCQD2208)
This publication has 58 references indexed in Scilit:
- Metal Doping Enabling Defective CoMo‐Layered Double Hydroxide Nanosheets as Highly Efficient Photosensitizers for NIR‐II Photodynamic Cancer TherapyAdvanced Materials, 2024
- Synergistic Interaction between Metal Single‐Atoms and Defective WO3−x Nanosheets for Enhanced Sonodynamic Cancer TherapyAdvanced Materials, 2024
- Recent Development of Copper‐Based Nanozymes for Biomedical ApplicationsAdvanced Healthcare Materials, 2023
- Self‐Driven Electricity Modulates d‐Band Electrons of Copper Single‐Atom Nanozyme for Boosting Cancer TherapyAdvanced Functional Materials, 2023
- Biofilm Microenvironment‐Responsive Self‐Assembly Nanoreactors for All‐Stage Biofilm Associated Infection through Bacterial Cuproptosis‐like Death and Macrophage Re‐RousingAdvanced Materials, 2023
- H2S‐Activated Ion‐Interference Therapy: A Novel Tumor Targeted Therapy Based on Copper‐Overload‐Mediated Cuproptosis and PyroptosisAdvanced Functional Materials, 2023
- Cuproptosis‐Driven Enhancement of Thermotherapy by Sequentially Response Cu2‐xSe via Copper Chemical TransitionAdvanced Functional Materials, 2023
- Construction of N, P Co‐Doped Carbon Frames Anchored with Fe Single Atoms and Fe2P Nanoparticles as a Robust Coupling Catalyst for Electrocatalytic Oxygen ReductionAdvanced Materials, 2022
- Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer TherapyAdvanced Materials, 2021
- Copper(I) Phosphide Nanocrystals for In Situ Self‐Generation Magnetic Resonance Imaging‐Guided Photothermal‐Enhanced Chemodynamic Synergetic Therapy Resisting Deep‐Seated TumorAdvanced Functional Materials, 2019